Company page

Hans Biomed Corp

Hans Biomed Corp, traded under the ticker 042520, is a public company based in Korea with a market capitalization of approximately 300.22 million USD. The company specializes in biomedical products and technologies. Its focus on innovation positions it as a notable player in the healthcare sector.

profile042520AI content: aiUpdated May 30, 2026/company/hans-biomed-corp
Hans Biomed Corp logo
Ticker
042520
Market cap
$300.2M
Sector
Health Services
Industry
Medical/Nursing Services